Raymond L. Comenzo

New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes

Giovanni Palladini, Angela Dispenzieri, Morie A. Gertz et al. · Journal of Clinical Oncology · 2012 · 969 citations

Medicine, Cardiology, Hematology +17

Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma

Ajai Chari, Dan T. Vogl, Maria Gavriatopoulou et al. · New England Journal of Medicine · 2019 · 673 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis

Efstathios Kastritis, Giovanni Palladini, Monique C. Minnema et al. · New England Journal of Medicine · 2021 · 668 citations · Full text

Life Sciences, Hematology, Pharmacology +15

Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma

Ajai Chari, Attaya Suvannasankha, Joseph W. Fay et al. · Blood · 2017 · 443 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation

Brian G.M. Durie, Robert A. Kyle, Andrew R. Belch et al. · The Hematology Journal · 2003 · 425 citations

Medicine, Hematology, Internal Medicine +16